An interventional study of Ewing Below Knee Amputation and Standard Below Knee Amputation in Peripheral Arterial Disease, sponsored by VA Office of Research and Development. Recruiting at 3 sites in United States. Per ClinicalTrials.gov, last updated 2026-11-18.
Sponsored by VA Office of Research and Development · Not applicable, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 16 studies in Peripheral Arterial Disease by VA Office of Research and Development — 5 open to participants now, 6 under way, 1 of them phase 3. Peripheral Arterial Disease · VA Office of Research and Development.
Among the 16 studies in Peripheral Arterial Disease by VA Office of Research and Development, this one is the 5th largest by planned enrollment of the 15 interventional ones that give a count, is the only one that started in 2026, is one of 12 with no phase, and was the 12th registered.
1,378 studies on the registry are indexed under Peripheral Arterial Disease; 276 are open to participants now.
Browse Peripheral Arterial Disease studies →5 of the 16 studies in Peripheral Arterial Disease by VA Office of Research and Development are open now, in 1 country. Recruiting first, the newest first:
VA Office of Research and Development · Sites in United States
Ages 21+
VA Office of Research and Development · Sites in United States
VA Office of Research and Development · Sites in United States
Ages 18+
VA Office of Research and Development · Sites in United States
Ages 35–89
By country, each count listing its studies:
Of the 193 Peripheral Arterial Disease studies recruiting now, 139 (72%) set no upper age limit and 9 (5%) stop at 75 or younger; 13 take children under 18; 19 take healthy volunteers.
This study: all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
16 studies; the count open now beside each. This study's row is marked.
First in 2011; this study’s year is marked. 1 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 120 is above the median of 70 across 927 interventional studies indexed under Peripheral Arterial Disease.
Median enrollment 56 across the 15 interventional studies, 47 across the 1 observational. Of the 8 that completed or were terminated, 5 (63%) have results posted.
This tab as a report to print or save as PDF → With an account.
VA Office of Research and Development is the lead sponsor of 1,774 studies on the registry; 394 are open to participants now.
Of its 213 completed or terminated interventional studies of FDA-regulated products, 185 (87%) have results posted.
4 of the studies in Peripheral Arterial Disease by VA Office of Research and Development that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05132439Phase 3VA Office of Research and DevelopmentMetfOrmin BenefIts Lower Extremities With Intermittent Claudication | 2027-02-28 |
| NCT06003855VA Office of Research and DevelopmentOxygen-guided Supervised Exercise Therapy | 2026-12-30 |
| NCT05048979VA Office of Research and DevelopmentTelehealth to Improve Functional Status and Quality of Life in Veterans With PAD | 2026-12-31 |
| NCT06033924VA Office of Research and DevelopmentTelehealth Delivered Home-based Walking for Vets With Peripheral Artery Disease | 2027-10-29 |
Add all 4 to your calendar (.ics) → With an account.
Among the 16 studies in Peripheral Arterial Disease by VA Office of Research and Development, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study follows the Pilot Investigation of Ewing Amputation for Veterans with PAD Undergoing a Below Knee Amputation. The 2 year pilot feasibility phase has concluded recruitment and enrollment.
The current phase is a 5 year randomized study of Ewing Below Knee Amputation vs. Standard Below Knee Amputation. If Veterans participate, they will be randomized to either Ewing Amputation or Standard Below Knee Amputation.
The scientific premise motivating this proposal is that Ewing Amputation is a promising surgical technique that may improve walking metrics in dysvascular Veterans by providing a better residual limb and improving pain and balance.
In preparation of this proposal, we have formed multi-disciplinary surgical teams at each site, and we have been supported by a clinical trial planning meeting to garner the considerable expertise in rehabilitation and amputee assessment from VA and DOD experts to assist in the design of this proposal, testing the overall hypothesis that: Ewing Amputation can help Veterans walk.
Major amputations lead to significant challenges for Veterans and their loved ones. Thus, amputations and the care of amputees are a major focus of the VHA. Hence, the tripartite goals of the VHA Amputation System of Care (ASoC) are to: provide state of the art care, maximize health and independence, and to be the provider of choice for amputated Veterans. Veterans undergo \~1000 transtibial amputations (TTA) annually, making TTA a commonly performed operation in the VA. Almost all Veterans requiring TTA are dysvascular with peripheral artery disease (PAD) and/or diabetes. TTA is a safe operation with a low 30-day mortality rate, and ambulation with prosthesis rates are much better for TTA versus transfemoral amputations (TFA). Since \~50% of Veterans are satisfied with their ambulation after major amputation, improving ambulation is an important benchmark forward in the care of Veterans. Importantly, the lower ambulation rates in Veterans are attributed to modifiable sequelae of major amputation, including: slower wound healing9,10; chronic pain, imbalance, and falls. Excitingly, new techniques can improve pain and balance and may improve wound healing/prevent falls. Ewing amputation (EA) recreates the agonist-antagonist myoneural interface (AMI) maintaining muscle tension, proprioception and limiting fibrofatty muscle degeneration of muscle flaps. EA also creates regenerative peripheral neural interfaces (RPNI) to improve pain control. Thus, EA may have a significant benefit to Veterans undergoing TTA.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Ewing Below Knee Amputation - incorporates RPNI and AMI
Procedure: Ewing Below Knee Amputation
Standard Below Knee Amputation
Procedure: Standard Below Knee Amputation
Ewing Below Knee Amputation - incorporates RPNI and AMI
Standard Below Knee Amputation
PROMIS Numeric Rating Scale
Patient reported rating scale to assess pain intensity and pain interference.
Time frame: 12 months
Socket Comfort Score
Patient reported rating scale to assess socket fit of prosthesis.
Time frame: 12 months
Phantom and Residual Limb Questionnaire
Patient reported questionnaire to assess sensation in phantom limb.
Time frame: 12 months
Lower Extremity Amputee Data Collection Form
Patient reported questionnaire to assess amputation system of care.
Time frame: 12 months
Lower Limb Mobility Rating Scale
Patient reported scale to assess movement with prosthetic leg.
Time frame: 12 months
Amputee Single Item Mobility Measure
Patient reported measure to assess current level of mobility.
Time frame: 12 months
Activities-specific Balance Scale
Patient reported scale to assess balance while performing every day activities.
Time frame: 12 months
Self-Reported Falls Measure
Patient reported one question survey to calculate falls in the previous month.
Time frame: 12 months
RAND Health Survey
Patient reported survey to assess general health while performing usual activities.
Time frame: 12 months
CRIS Fixed Form Instrument
Patient reported rating scale to assess usual activities in previous two weeks.
Time frame: 12 months
Patient Two Minute Walk Test
To measure distance patient can walk without assistance in 2 minutes.
Time frame: 12 months
Patient Timed Up and Go Test
To measure amount of time patient walks 3 meters.
Time frame: 12 months
Berg Balance Scale
To assess the patient's sitting and standing balance levels.
Time frame: 12 months
Amputee Mobility Predictor Questionnaire
To measure the patient's sitting, standing, turning and walking/stepping with and without prosthesis.
Time frame: 12 months
Plan to share: No
No publications or documents are linked to this record.
Started Feb 2026 (actual). Primary completion is estimated for Feb 2030, 48 months after the start.
Of 261 non-industry interventional studies with no phase under Peripheral Arterial Disease, half reached primary completion within 33 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 64. This study's planned 48 months is above that.
Counting every sponsor, half of 386 studies reached it within 31 months; a quarter within 17 and three quarters within 55.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
VA Office of Research and Development →